DUBAG GROUP
Thomas-Wimmer-Ring 1
D-80539 München
Germany
Tel: +49 89 45 209 45 0
DUBAG GROUP
Thomas-Wimmer-Ring 1
D-80539 München
Germany
Tel: +49 89 45 209 45 0
We’re proud to announce that our LEO III Fund has signed a purchase agreement for the acquisition of IVOSTUD GmbH and its subsidiaries from Doncasters Limited, a wholly owned indirect subsidiary of the NYSE-listed DPC Holdings PLC.
Based in Breckerfeld, IVOSTUD is a specialized developer and manufacturer of stud welding systems and the welding studs and fastening elements they use. Its offering ranges from fixed-mounted systems to robotic weld heads for high-volume production, complemented by installation, maintenance, and spare parts services. IVOSTUD employs around 170 people, with production sites in Breckerfeld and Radevormwald and sales and service locations in the US, Mexico, France, the UK and China. Its customers are mainly automotive manufacturers and their suppliers.
IVOSTUD stood out to us for its engineering depth, which goes back to 1967 and its predecessor, Nelson Bolzenschweiß-Technik. Beyond that, it has a true single-source offering that combines welding systems, a portfolio of more than 340 stud types, and comprehensive service and application support across the entire product life cycle. Deep technical know-how, long-standing customer relationships, and a clear carve-out story.
Our ambition together with management:
Christoph Moedder, Partner at DUBAG Group: “IVOSTUD is a well-established company with decades of stud welding expertise and long-standing relationships with leading automotive manufacturers and suppliers. We look forward to working with the management team and all employees to position IVOSTUD for further growth in Europe and North America.”
This transaction reflects our continued commitment to partnering with exceptional industrial businesses in complex corporate carve-outs and supporting their next phase of independent growth.
We would like to thank Doncasters for a trustful and constructive process, and our full team for their outstanding work:
Deal Team: DUBAG
Legal: HEUKING – Andreas Lenz & Bastian Rieck
The LEO III Fund, advised by DUBAG Group, has signed an agreement to acquire JPT Peptide Technologies GmbH from BioNTech Diagnostics GmbH.
Founded in 2004 as a spin-off from Jerini AG, JPT is one of the leading international providers of peptide-based research and development solutions. Operating from Berlin, the company serves more than 20,000 customers in over 100 countries across biopharma, cell and gene therapy, vaccine development, immunology, proteomics and academic research. JPT employs approximately 130 people and has been ISO 9001 certified since 2004.
As a stand-alone company under the LEO III Fund, JPT will continue to invest in its technology platform, aims to accelerate its international development across Europe and North America, and plans to further diversify its portfolio of peptide solutions.
Sebastian Stalter, Director at DUBAG Group, comments: “JPT is an outstanding company with world-class peptide expertise and a loyal international customer base. We very much look forward to working with Aurélien Claeyssen, his management team and the entire team, and to jointly positioning JPT for growth in Europe and North America.”
We would like to thank BioNTech on a trusted and constructive process and look forward to working with JPT.
Deal Team: DUBAG
Christoph Mödder, Sebastian Stalter, Tolga Dahmen, Maren Blindert
Legal Advisory: Noerr
Dr. Markus A. Braun, Manuel Lomb, Boris Alexander Blunck, Nico Rosenfelder
IT Advisory: Valantic
Download the press release here.
We’re proud to announce that our LEO III Fund has signed a purchase agreement for the acquisition of Holcim Technical Solutions and Products GmbH (HTSP) from Holcim.
Based in Edingen-Neckarhausen, HTSP is a specialized manufacturer of engineered elastomer solutions and high-performance rubber materials — serving customers across aerospace, mechanical engineering, mobility, medical technology, and road marking applications.
What makes HTSP particularly compelling: a strong and well-established position in civil aviation flooring, where its engineered, non-textile materials meet the industry’s stringent requirements for flammability, durability, and slip resistance. And beyond aviation, a robust portfolio across several highly specialized sectors — from drinking-water-certified rubber sheeting to critical insulating and building solutions and an established road-marking business. A technically demanding profile, a loyal customer base, and a clear carve-out story.
Our ambition together with management:
Sebastian Stalter, Director at DUBAG Group:
“We are delighted to partner with HTSP’s management team and to support the next chapter in the company’s development. Together, we will deepen the focus on HTSP’s customers and their technological needs, and look forward to securing a strong future in the Mannheim/Heidelberg region.”
This transaction reflects our continued commitment to partnering with exceptional industrial businesses in complex corporate carve-outs and supporting their next phase of independent growth.
We would like to take this opportunity to recognise the exceptional contribution of our full team:
Deal Team: DUBAG
Dr. Michael Schumann, Sebastian Stalter, Alexander Preuss & Sven Lüdiger
Legal Advisor: Taylor Wessing
Sven Schweneke & Florian Leitsbach
IT Advisory: Valantic
We’re proud to announce that our LEO III Fund has successfully completed the acquisition of H.K.O. Isolier- und Textiltechnik GmbH (HKO) from Saint-Gobain.
Based in Oberhausen, HKO is a specialist manufacturer of highly specialized thermal insulation, fire protection, and technical textile products — serving demanding industrial end-markets worldwide, from high-temperature insulation to EV battery fire protection and personal protective equipment.
This transaction marks the first step in carving HKO out of the Saint-Gobain Group and re-establishing the company as a fully independent, growth-oriented business.
Our ambition together with management:
Christoph Mödder, Partner at DUBAG Group: “With our hands-on approach and proven track record in developing industrial mid-sized companies, we aim to position HKO as a strong, sustainably growing market leader.”
This investment reflects our continued commitment to partnering with exceptional industrial businesses in complex corporate carve-outs and supporting their next phase of independent growth.
We would like to take this opportunity to recognise the exceptional contribution of our full team:
Deal Team: DUBAG
Legal Advisor: Taylor Wessing
Sven Schweneke & Florian Leitsbach
IT Advisory: Valantic
Stephan Herteux & Mark Reinold
Financial Due Diligence: Baker Tilly
We are pleased to announce that the Lenbach Equity Opportunities III Fund, advised by the DUBAG Group, has successfully completed the acquisition of ItalPresseGauss S.r.l. from Altor.
Based in Italy, ItalPresseGauss is a well-established provider of advanced die-casting technologies, with a strong track record in high-pressure aluminum die-casting solutions, automated work cells, and tailored production systems for customers worldwide.
With its deep engineering expertise and long-standing customer relationships, ItalPresseGauss is ideally positioned to benefit from key industry trends – particularly the ongoing electrification of the automotive sector and the increasing demand for lightweight components.
Our ambition together with management:
Pursue both organic growth and selective M&A opportunities
Emanuel Cattanei, Partner at DUBAG Group:
“We are very pleased to support ItalPresseGauss in this next stage of its development. The company combines a strong market position with significant growth potential. Together with management, we aim to further strengthen innovation, sharpen the customer offering, and support expansion across key markets.”
This investment underlines our continued commitment to partnering with strong industrial businesses in special situations and supporting their next phase of growth.
We would like to thank all parties involved for the constructive and professional collaboration throughout the process.
The DUBAG deal team
Sven Lüdiger
Sebastian Stalter
Emanuel Cattanei
Legal Advisor
Daniela Andreatta and her team from Orrick Italia
M&A Advisor
Deloitte Advisory was appointed as expert in analyzing the business plan and the financial sustainability
We are pleased to announce that Lenbach Equity Opportunities III (“LEO III Fund”), advised by DUBAG Group, has signed a put option agreement with JTEKT Corporation for the acquisition of 100% of JTEKT’s automotive steering business serving European OEMs (“Zenith”).
The transaction marks an important step in establishing Zenith as an independent, innovation-driven European Tier-1 supplier with strong engineering DNA and a clear ambition to further strengthen its position as a long-term technology partner to leading OEMs.
As a standalone company, Zenith will operate with full organizational autonomy, dedicated governance and independent systems. Together with management, we aim to implement a structured transformation program focused on operational excellence, accelerated decision-making and continued investment in next-generation steering technologies – including Steer-by-Wire
The transaction is subject to customary information and consultation procedures as well as regulatory approvals. Closing is expected in early autumn 2026.
Zenith generated revenues of EUR 845 million across seven sites in FY25. This transaction is the largest investment by DUBAG since its inception and an important milestone in the growth of our organization.
We would like to thank all parties involved for the constructive and professional collaboration throughout the process.
The DUBAG deal team:
Sven Lüdiger
Fabian Hilke
Sebastian Stalter
Christoph Mödder
Legal:
Sven Schweneke and his team from Taylor Wessing
Marguerite Galois-Boyé and her team from DEGROUX BRUGÈRE
Munich/Barcelona, Juli 31, 2025 – We’re proud to announce that LEO III Fund has successfully acquired PronoKal Group from Nestlé Health Science.
With this acquisition, PronoKal will now operate as an independent company – ready to strengthen its leading position in the fast-growing ketogenic nutrition market.
Backed by a strong foundation in science-based, medically supervised nutrition, the company is ideally positioned to accelerate innovation, expand internationally, and deliver sustainable health solutions with real impact.
This transaction reflects DUBAG Group’s ongoing commitment to unlocking value in complex corporate carve-outs and supporting long-term, purpose-driven growth.
A big thank-you to Nestlé Health Science for the trustful collaboration and to everyone who contributed to the success of this transaction, especially our DUBAG deal team for their dedication and tireless efforts:
Deal Team: Dr. Michael Schumann, Emanuel Cattanei, Sebastian Stalter & Fabian Hilke
Legal: Sven Schweneke & Daniel Mursa (Taylor Wessing) & Emilio Prieto (Ecija)
On September 18, 2025, we had the pleasure of welcoming our investors, partners and portfolio companies to the Annual General Meeting 2025 of LEO II & LEO III in Munich.
The event, at which both funds came together for the first time, marked an important milestone on our joint journey. It reflected 16 years of market presence since our foundation in 2009 – with a combined portfolio turnover of over 650 million euros and more than 2,500 employees in our companies.
Like a flock of birds flying in perfect formation, our success is based on collaboration, coordination and common goals – between investors, management teams and partners across Europe.
The Annual General Meeting provided an opportunity to share perspectives, celebrate successes and look ahead together to the next chapter of growth and value creation.
A big thank you to all participants for their trust, commitment and inspiring contributions.
Here’s to continued momentum and a shared flight to new possibilities.
In July 2025, Maren Blindert joined the DUBAG team as an Investment Analyst.
She graduated with a Bachelor of Science in International Business with a focus on Finance from Maastricht University and holds an International Master of Finance from Católica Lisbon School of Business & Economics. Maren started at DUBAG as an Intern before joining as a full-time Analyst.
Prior to DUBAG, she gained valuable experience at Accuracy Germany GmbH and in the M&A Team of AdEx Partners GmbH, where she supported financial due diligence and strengthened her expertise in transaction processes. Further, she gained insights into private equity co-investments and portfolio management FCM Frédéric Capital Management.
We are delighted to welcome Maren to the team and look forward to a successful collaboration.
Munich/Ditzingen/Schio, July 4, 2025: In line with its strategy of investing in high-potential industrial assets, the LEO III Fund has signed an agreement with TRUMPF to acquire the Additive Manufacturing (Laser Metal Fusion (LMF) / Powder Bed Fusion (PBF/LPBF)) business, a pioneer in additive manufacturing technologies. The transaction highlights DUBAG’s role as a reliable and responsible partner for large corporations in executing complex carve-outs.
Strategic realignment of the Business following the Carve-out
The new group aims to establish itself as a technologically leading, internationally operating solution provider for metallic 3D printing. The focus is on the development, manufacturing, implementation, and sales of comprehensive solutions that go beyond the mere delivery of machines. As part of the carve-out, internal structures and processes will be simplified to address customer needs more quickly and effectively worldwide. Customers will benefit not only from innovative equipment but also from extensive application consulting, process development, automation solutions, and integration concepts covering the entire value chain.
In particular, the specific requirements of OEMs and their suppliers in the aerospace and medical technology industries will be addressed, as well as those of specialized contract manufacturers focusing on industrial series production in metallic 3D printing. The future market strategy targets the aerospace, medical technology, dental, and general industrial sectors.
The completion of the transaction is subject to approval by relevant authorities and the fulfillment of all contractually agreed conditions.
A big thank-you to everyone who supported us on this transaction.
Especially our DUBAG deal team for their dedication and tireless work throughout the process:
Dealteam: Emanuel Cattanei, Sebastian Stalter, Alexander Preuss, Raphael Marold and Sven Lüdiger
Legal: Sven Schweneke, Laurenz Kiefer, and their team Taylor Wessing, as well as Daniela Andreatta and her team from Orrick, Herrington & Sutcliffe LLP in Italy
DUBAG GROUP
Thomas-Wimmer-Ring 1
D-80539 München
Germany
Tel: +49 89 45 209 45 0

DUBAG GROUP
Thomas-Wimmer-Ring 1
D-80539 München
Germany
Tel: +49 89 45 209 45 0
This site uses cookies to optimize your experience, remember your preferences, and analyse traffic.
Accept settingsDo not acceptPersonalizeWe may request cookies to be set on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience, and to customize your relationship with our website.
Click on the different category headings to find out more. You can also change some of your preferences. Note that blocking some types of cookies may impact your experience on our websites and the services we are able to offer.
These cookies are strictly necessary to provide you with services available through our website and to use some of its features.
Because these cookies are strictly necessary to deliver the website, refusing them will have impact how our site functions. You always can block or delete cookies by changing your browser settings and force blocking all cookies on this website. But this will always prompt you to accept/refuse cookies when revisiting our site.
We fully respect if you want to refuse cookies but to avoid asking you again and again kindly allow us to store a cookie for that. You are free to opt out any time or opt in for other cookies to get a better experience. If you refuse cookies we will remove all set cookies in our domain.
We provide you with a list of stored cookies on your computer in our domain so you can check what we stored. Due to security reasons we are not able to show or modify cookies from other domains. You can check these in your browser security settings.
We also use different external services like Google Webfonts, Google Maps, and external Video providers. Since these providers may collect personal data like your IP address we allow you to block them here. Please be aware that this might heavily reduce the functionality and appearance of our site. Changes will take effect once you reload the page.
Google Webfont Settings:
Google Map Settings:
Google reCaptcha Settings:
Vimeo and Youtube video embeds:
